Search

Search Constraints

You searched for: Author/Creator French, Pim J

Search Results

1. Bevacizumab and temozolomide in patients with first recurrence of WHO grade II and III glioma, without 1p/19q co-deletion (TAVAREC): a randomised controlled phase 2 EORTC trial. Issue 9 (September 2018)

2. Combined molecular subtyping, grading, and segmentation of glioma using multi-task deep learning. Issue 2 (5th July 2022)

3. Differences in spatial distribution between WHO 2016 low-grade glioma molecular subgroups. Issue 1 (31st May 2019)

4. Differences in spatial distribution between WHO 2016 low-grade glioma molecular subgroups. Issue 1 (31st May 2019)

5. EGFR mutations are associated with response to depatux-m in combination with temozolomide and result in a receptor that is hypersensitive to ligand. Issue 1 (9th December 2019)

6. Fusion transcripts and their genomic breakpoints in polyadenylated and ribosomal RNA–minus RNA sequencing data. Issue 12 (9th December 2021)

7. Generation, characterization, and drug sensitivities of 12 patient-derived IDH1-mutant glioma cell cultures. Issue 1 (2nd August 2021)

8. IDH1/2 wildtype gliomas grade 2 and 3 with molecular glioblastoma-like profile have a distinct course of epilepsy compared to IDH1/2 wildtype glioblastomas. Issue 4 (16th August 2022)

10. Prognostic significance of genome-wide DNA methylation profiles within the randomized, phase 3, EORTC CATNON trial on non-1p/19q deleted anaplastic glioma. Issue 9 (29th April 2021)